Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice.
about
Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Ruxolitinib sensitizes ovarian ...... ival in immune competent mice.
@en
Ruxolitinib sensitizes ovarian ...... ival in immune competent mice.
@nl
type
label
Ruxolitinib sensitizes ovarian ...... ival in immune competent mice.
@en
Ruxolitinib sensitizes ovarian ...... ival in immune competent mice.
@nl
prefLabel
Ruxolitinib sensitizes ovarian ...... ival in immune competent mice.
@en
Ruxolitinib sensitizes ovarian ...... ival in immune competent mice.
@nl
P2093
P2860
P50
P356
P1433
P1476
Ruxolitinib sensitizes ovarian ...... ival in immune competent mice.
@en
P2093
Christina Gavegnano
Mark C Poznansky
Mojgan A Abbaslou
Raymond F Schinazi
Xiaoyun Tong
P2860
P304
94040-94053
P356
10.18632/ONCOTARGET.21541
P407
P577
2017-10-04T00:00:00Z